Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital-Reference-Cited by-同舟云学术

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital

Published:2017-01-24 Issue:4 Volume:45 Page:425-431
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Pichenot Marie,Héquette-Ruz Rozenn,Le Guern Remi,Grandbastien Bruno,Charlet Clément,Wallet Frédéric,Schiettecatte Sophie,Loeuillet Fanny,Guery Benoit,Galperine Tatiana

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s15010-017-0981-8/fulltext.html

Reference48 articles.

1. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34.

2. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect. 2012;81:1–14.

3. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198–208.

4. Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14:1208–19.

5. Ferrer Márquez M, Hernández Martínez Á, Reina Duarte Á, Rosado Cobián R. Current status of the treatment of fulminant colitis. Cir Esp. 2015;93:276-82.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infections: A Review of the Current Literature and Paradigm Shift after 2021;Antibiotics;2022-09-07

2. Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study;Journal of Antimicrobial Chemotherapy;2022-04-11

3. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults;Clinical Microbiology and Infection;2021-12

4. A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France;Journal of International Medical Research;2021-06

5. Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes;Infection;2021-01-08